mRNA Stock Chart - Search News

FDA to review Moderna's mRNA flu vaccine

Moderna jumps above 20-day moving average on FDA flu vaccine review. Should you buy MRNA stock here?

Moderna (MRNA) stock closed higher on Wednesday after the FDA reversed its earlier refusal-to-file decision on the company’s mRNA-1010 seasonal influenza vaccine. As the regulatory agency agreed to review MRNA’s revised application,

Investing.com South Africa · 3d

Moderna stock rises after FDA agrees to review seasonal flu vaccine

Blockonomi · 10d

Moderna (MRNA) Stock Falls 9% After FDA Rejects Flu Vaccine Application

· 2d

FDA reverses course on Moderna's flu vaccine

The FDA says it will now review a new m-r-n-a flu vaccine from Moderna.

· 2d

FDA will review new flu vaccines from Moderna, the agency said

· 2d

Moderna Wins Regulatory Reversal as U.S. FDA Agrees to Evaluate New Shot

Schaeffer's Investment Research

Moderna Stock Pops as FDA Application Moves Forward

Moderna (MRNA) stock is on the rise after the U.S. Food & Drug Administration (FDA) accepted the company's flu vaccine application for review

Barron's

Moderna Inc.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock quotes are delayed as per exchange requirements.

Nasdaq

December 26th Options Now Available For Moderna (MRNA)

Investors in Moderna Inc (Symbol: MRNA) saw new options begin trading today, for the December 26th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA options chain for the new December 26th contracts and identified ...

Seeking Alpha

Moderna: More Downside In The Stock But The Cancer Vaccine Offers Potential

MRNA remains under pressure in 2025, despite recent next-gen COVID vaccine approval and upcoming cancer vaccine trial readouts. MRNA has a fully enrolled, 1089-patient study of mRNA-4157 in melanoma ongoing, with the company guiding for a 2026 readout.